◆ 会议时间：2026年4月21-24日
◆ 会议地点：英国 爱丁堡

◆ 会议简介：

2026年第39届欧洲免疫遗传学与组织相容性大会(EFI)将于2026年4月21-24日在英国苏格兰爱丁堡举行。

欧洲免疫遗传学联合会(EFI)(以前称为欧洲免疫遗传基金会)于1985年3月正式成立，其宗旨是支持欧洲免疫遗传学作为医学学科的发展，并促进该领域的研究和培训宣；提供一个交流科学信息的论坛，并增强年轻科学家和该领域其他科学家的技能和知识；促进免疫遗传学数据库的组织和使用；与目标相似的机构建立联系合作；等等。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)

EFI 2026 - 39th European Immunogenetics and Histocompatibility Conference

Date:
April 21-24, 2026

Location:
Edinburgh, Scotland

摘要征文投稿：

Abstract submission opens 8 September 2025

Abstract submission deadline 1 December 2025

Notification about oral/poster presentation 1 February 2026

点此提交摘要>>>Submit Abstract>>>

Please note, upon first visit, please click on "Sign up to Oxford Abstracts" at the bottom of the page

Requirements

When submitting your abstract please follow these abstract submission instructions.

• All papers must be original and not simultaneously submitted to another journal or conference
• The abstract must
  • be written in scientific English
  • have a maximum length of 2000 characters (including spaces)
  • have a short informative title containing the major keywords (max 200 characters including spaces). The title should not contain abbreviations
  • be a single paragraph without any heading
• Minimize the use of abbreviations, and do not cite references in the abstract
• The author's institutional affiliations must not be included in the abstract to ensure anonymity of the process
• Submitters will be asked to choose either Oral/Poster or Poster only for their abstract. The use of Oral/Poster is encouraged to maximise the abstracts being considered for the oral sessions.
• All accepted abstracts will be published in the HLA journal, and available online. By submitting your abstract, you consent to give EFI permission to publish it.

The following submission categories are available. Submitters are asked to select one primary category that best aligns with their abstract content and, if applicable, a secondary category.  

• Bioinformatics, Artificial Intelligence
• Cancer Immunogenetics
• Haematopoietic Stem Cell Transplantation
• HLA antigen processing and presentation
• Immunogenetics and Infections
• Immunological Tolerance
• Immunotherapy & Gene Therapy
• MHC Evolution, Anthropology & Population Genetics
• New Technologies, Various
• NK cells and KIR
• Reproductive Immunity
• Solid Organ Transplantation
• Other

◆ 参会对象：免疫学家，医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。